NASDAQ:HSDT - Helius Medical Technologies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$13.77
▼ -0.13 (-0.94%)
1 month | 3 months | 12 months
Get New Helius Medical Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HSDT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HSDT

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for Helius Medical Technologies in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $13.77.
Buy
The current consensus among 2 contributing investment analysts is to buy stock in Helius Medical Technologies. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/9/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/8/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/7/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/31/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/2/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/12/2021LADENBURG THALM/SH SHInitiated CoverageBuyLow
i
8/12/2020OppenheimerReiterated RatingHoldHigh
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
5/12/2020OppenheimerInitiated CoverageHoldHigh
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
8/9/2019BTIG ResearchReiterated RatingHoldN/A
i
Rating by Sean Lavin at BTIG Research
4/16/2019BTIG ResearchDowngradeBuy ➝ NeutralHigh
i
4/10/2019OppenheimerDowngradeOutperform ➝ HoldHigh
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
3/18/2019BTIG ResearchReiterated RatingBuyHigh
i
3/5/2019OppenheimerInitiated CoverageBuy$350.00High
i
Rating by Steven Lichtman at Oppenheimer Holdings Inc.
1/27/2019BTIG ResearchReiterated RatingBuy$490.00Low
i
11/20/2018BTIG ResearchUpgradeNeutral ➝ Buy$490.00Medium
i
6/19/2018BTIG ResearchReiterated RatingBuy ➝ Neutral$490.00High
i
5/17/2018BTIG ResearchInitiated CoverageBuy$490.00Low
i
4/19/2016Greenridge GlobalUpgradeHold ➝ BuyN/A
i
Rating by W. Gregozeski at Greenridge Global
(Data available from 3/2/2016 forward)
Helius Medical Technologies logo
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational Portable Neuromodulation Stimulator (PoNS), that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.
Read More

Today's Range

Now: $13.77
$13.62
$13.92

50 Day Range

MA: $14.83
$13.20
$16.90

52 Week Range

Now: $13.77
$8.72
$34.00

Volume

1,350 shs

Average Volume

157,568 shs

Market Capitalization

$31.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.72

Frequently Asked Questions

What sell-side analysts currently cover shares of Helius Medical Technologies?

The following sell-side analysts have issued research reports on Helius Medical Technologies in the last twelve months: LADENBURG THALM/SH SH, Oppenheimer Holdings Inc., and Zacks Investment Research.
View the latest analyst ratings for HSDT.

What is the current price target for Helius Medical Technologies?

0 Wall Street analysts have set twelve-month price targets for Helius Medical Technologies in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Helius Medical Technologies in the next year.
View the latest price targets for HSDT.

What is the current consensus analyst rating for Helius Medical Technologies?

Helius Medical Technologies currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HSDT will outperform the market and that investors should add to their positions of Helius Medical Technologies.
View the latest ratings for HSDT.

What other companies compete with Helius Medical Technologies?

How do I contact Helius Medical Technologies' investor relations team?

Helius Medical Technologies' physical mailing address is 642 NEWTOWN YARDLEY ROAD SUITE 100, NEWTOWN PA, 18940. The company's listed phone number is (215) 944-6100 and its investor relations email address is [email protected] The official website for Helius Medical Technologies is heliusmedical.com.